Amphastar Pharmaceuticals Stock Forecast

Buy or Hold candidate since Nov 10, 2025 Loss -0.38%

The Amphastar Pharmaceuticals stock price fell by -0.153% on the last day (Monday, 17th Nov 2025) from $26.06 to $26.02. It has now fallen 3 days in a row. During the last trading day the stock fluctuated 3.27% from a day low at $25.70 to a day high of $26.54. The price has fallen in 6 of the last 10 days but is still up by 2.85% over the past 2 weeks. Volume has increased on the last day by 136 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 418 thousand shares were bought and sold for approximately $10.87 million.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -18.21% during the next 3 months and, with a 90% probability hold a price between $17.12 and $22.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

AMPH Signals & Forecast

The Amphastar Pharmaceuticals stock holds a sell signal from the short-term Moving Average; at the same time, however, there is a buy signal from the long-term average. Since the short-term average is above the long-term average there is a general buy signal in the stock giving a positive forecast for the stock. On further gains, the stock will meet resistance from the short-term Moving Average at approximately $26.23. On a fall, the stock will find some support from the long-term average at approximately $25.13. A break-up through the short-term average will send a buy signal, whereas a breakdown through the long-term average will send a sell signal. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Wednesday, November 12, 2025, and so far it has fallen -6.50%. Further fall is indicated until a new bottom pivot has been found. Volume rose on falling prices yesterday. This may be an early warning and the stock should be followed more closely.

Support, Risk & Stop-loss for Amphastar Pharmaceuticals stock

On the downside, the stock finds support just below today's level from accumulated volume at $24.52 and $24.23. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Amphastar Pharmaceuticals finds support just below today's level at $24.52. If this is broken, then the next support from accumulated volume will be at $24.23 and $24.03.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.84 between high and low, or 3.27%. For the last week, the stock has had daily average volatility of 4.61%.

Our recommended stop-loss: $24.78 (-4.78%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 3 days ago.)

Trading Expectations (AMPH) For The Upcoming Trading Day Of Tuesday 18th

For the upcoming trading day on Tuesday, 18th we expect Amphastar Pharmaceuticals to open at $26.09, and during the day (based on 14 day Average True Range), to move between $25.44 and $26.60, which gives a possible trading interval of +/-$1.16 (+/-4.57%) up or down from last closing price. If Amphastar Pharmaceuticals takes out the full calculated possible swing range there will be an estimated 4.57% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $26.12 (0.38%) than the support at $24.52 (5.76%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is Amphastar Pharmaceuticals stock A Buy?

Amphastar Pharmaceuticals holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

Current score: 0.268 Hold/Accumulate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on November 18, 2025 - $26.09 ( 0.256%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk